Synovus Financial Corp purchased a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,062 shares of the technology company's stock, valued at approximately $463,000.
Other institutional investors have also bought and sold shares of the company. Cornerstone Planning Group LLC bought a new stake in Amdocs during the first quarter valued at $27,000. AdvisorNet Financial Inc boosted its stake in Amdocs by 382.9% during the first quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company's stock worth $31,000 after acquiring an additional 268 shares in the last quarter. NBC Securities Inc. bought a new position in Amdocs during the first quarter worth $31,000. Cullen Frost Bankers Inc. bought a new position in Amdocs during the first quarter worth $39,000. Finally, SVB Wealth LLC bought a new position in Amdocs during the first quarter worth $43,000. Institutional investors own 92.02% of the company's stock.
Analyst Ratings Changes
DOX has been the topic of several research analyst reports. Wolfe Research initiated coverage on shares of Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating on the stock. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Four analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $105.33.
Check Out Our Latest Report on Amdocs
Amdocs Stock Performance
NASDAQ:DOX traded up $0.98 on Friday, reaching $85.57. 1,357,151 shares of the company's stock were exchanged, compared to its average volume of 950,551. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The firm has a market cap of $9.66 billion, a price-to-earnings ratio of 17.36, a P/E/G ratio of 1.57 and a beta of 0.54. Amdocs Limited has a 52 week low of $78.61 and a 52 week high of $95.41. The stock has a fifty day simple moving average of $88.52 and a 200-day simple moving average of $88.79.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The company had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same period last year, the business earned $1.62 earnings per share. Amdocs's revenue was down 8.4% compared to the same quarter last year. As a group, sell-side analysts predict that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is 42.80%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.